3D cross-section of skin showing golden liquid droplets absorbing into skin cells
Impetigo: Clinical Presentation, Diagnosis, Treatment, and Prevention

Impetigo is a highly contagious, superficial bacterial skin infection primarily affecting young children aged 2 to 5 years, though older children and adults remain susceptible. Understanding its variants, diagnosis, targeted therapy, and containment strategies is critical to managing outbreaks and avoiding unnecessary systemic antibiotic use.

Etiology & Pathophysiology

Impetigo is caused by Staphylococcus aureus and/or Group A Beta-Hemolytic Streptococcus (GAS; Streptococcus pyogenes). Infection typically occurs following minor epidermal barrier breakdown (e.g., abrasions, insect bites, scratches, eczema), but can also colonize intact skin.

1. Clinical Presentation: Nonbullous vs. Bullous Impetigo

Feature Nonbullous Impetigo (70% of Cases) Bullous Impetigo
Primary Pathogen S. aureus, Group A Streptococcus, or co-infection Exfoliative toxin-producing S. aureus strains
Pathomechanics Direct bacterial invasion of superficial epidermis Exfoliative toxins target desmoglein-1, splitting the upper epidermal layer
Classic Appearance Small papules/vesicles rupture into superficial lesions with honey-colored (golden) crusts Large, fragile, fluid-filled bullae (clear to cloudy) that rupture, leaving shallow raw erosions
Typical Locations Perioral and perinasal facial regions, exposed limbs Trunk, intertriginous areas, extremities

🚨 Red Flag Escalation: Deep Tissue Invasion & Systemic Signs

Uncomplicated impetigo is strictly localized and rarely presents with fever or constitutional symptoms. Clinicians must evaluate for potential complications or alternative diagnoses if red flags emerge:

  • Ecthyma: A deeper ulcerative form of impetigo extending into the dermis, leaving punched-out ulcers with thick crusts and scarring.
  • Cellulitis / Erysipelas: Rapidly spreading erythema, warmth, severe pain, induration, or high fever.
  • Post-Streptococcal Glomerulonephritis (PSGN): A rare late non-suppurative complication following Group A Strep impetigo (monitor for hematuria/edema).

2. Diagnostic Approach & MRSA Considerations

Diagnosis is predominantly clinical based on characteristic lesion morphology and location.

Diagnostic Strategy Indications & Clinical Context
Clinical Diagnosis Sufficient for uncomplicated cases presenting with classic honey-colored crusts or intact bullae. Routine culture is unnecessary.
Bacterial Culture & Sensitivity Indicated when:
• First-line empic treatment fails
• Infection repeatedly recurs
• Local outbreak monitoring is required
• Suspected Methicillin-Resistant S. aureus (MRSA)

3. Evidence-Based Treatment Protocol

Severity / Extent Recommended Regimen Clinical Notes
Localized / Limited Lesions
(Nonbullous)
Topical Antibiotic Ointment
• Mupirocin 2% ointment
• Retapamulin 1% ointment
First-line standard of care. Applied directly to cleaned, debrided crusts to avoid systemic side effects.
Extensive / Bullous / Outbreak Oral Antibiotics
• Cephalexin
• Dicloxacillin
• Clindamycin or Trimethoprim-Sulfamethoxazole (if MRSA suspected)
Indicated for widespread lesions, bullous form, multiple household members affected, or failed topical therapy.

Mnemonic: CRUST – Infection Control & Home Care

  • C – Clean & Cover: Gently cleanse affected areas with mild soap and water; cover loosely with clean bandages.
  • R – Restrict Sharing: Do not share towels, washcloths, clothing, or bedding with household members.
  • U – Uncut Nails Hazard: Keep fingernails short and clean to prevent autoinoculation and secondary trauma from scratching.
  • S – Sanitization: Frequent hand hygiene with soap/water or alcohol-based rubs, especially after touching lesions.
  • T – Time to Return: Children may typically return to school or daycare after completing 24 hours of appropriate antibiotic therapy and when active lesions are covered.

High-Yield Exam & Practice Pearls

  • Classic Landmark: Facial honey-colored (golden) crusted sores around the mouth/nose = Nonbullous Impetigo.
  • Toxin Mechanism: Bullous impetigo is mediated by S. aureus exfoliative toxins cleavage of desmoglein-1 in the superficial epidermis.
  • First-Line Topical: Mupirocin ointment is preferred for limited nonbullous lesions over oral regimens to reduce antibiotic resistance.
  • Deep Form Warning: Ulcerative lesions extending through the epidermis into the dermis represent Ecthyma, which heals with scarring.
  • Transmission Control: Infection remains highly contagious until 24 hours after initiating effective antibiotic treatment.

Board Exam Recall: Nonbullous impetigo = S. aureus/GAS + honey-colored crusts | Bullous impetigo = S. aureus exfoliative toxin + clear bullae | Treatment = Mupirocin topical for local, Cephalexin oral for widespread | Ecthyma = deep dermal ulcers. Prepared strictly for healthcare educational purposes.

Published on
August 31, 2026
|
Last Reviewed on
September 17, 2026
Connecting You and Primary Care
© 2026 TME HEALTHCARE. All rights reserved.